Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001910914 | SCV002167082 | likely benign | Alagille syndrome due to a JAG1 point mutation | 2023-05-20 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004741129 | SCV005361534 | uncertain significance | JAG1-related disorder | 2024-09-10 | no assertion criteria provided | clinical testing | The JAG1 c.2307C>T variant is not predicted to result in an amino acid change (p.=). This variant is predicted to alter splicing based on available splicing prediction software (SpliceAI, Jaganathan et al. 2019. PubMed ID: 30661751). However, the use of computer prediction softwares is not equivalent to functional evidence. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.00088% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |